STOCK TITAN

NHC (NHC) CFO Kidd exercises stock options and settles taxes in shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

National Healthcare Corp SVP and CFO Brian F. Kidd exercised stock options and settled related obligations in shares. He exercised derivative securities covering 4,500 shares of common stock through option exercises and had 3,134 shares of common stock withheld by the company to pay the exercise price and tax withholding obligations. These transactions are compensation-related and were granted under the 2020 Omnibus Equity Incentive Plan. Kidd also retains unexercised options linked to 14,000 and 4,147 underlying common shares at exercise prices of $157.13 and $53.94 per share, respectively.

Positive

  • None.

Negative

  • None.
Insider KIDD BRIAN F
Role SVP, CFO
Type Security Shares Price Value
Exercise Option to Purchase Common Stock 4,000 $0.00 --
Exercise Option to Purchase Common Stock 500 $0.00 --
Exercise Common Stock 4,000 $94.10 $376K
Exercise Common Stock 500 $90.62 $45K
Tax Withholding Common Stock 3,134 $197.96 $620K
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
Holdings After Transaction: Option to Purchase Common Stock — 4,000 shares (Direct, null); Common Stock — 33,130 shares (Direct, null)
Footnotes (1)
  1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Total amount of shares beneficially owned following transactions reported on this form.
Option exercises 4,500 shares Derivative exercises (M code) into common stock
Tax withholding shares 3,134 shares Shares withheld to pay exercise price and taxes
Option strike price $90.62 per share Exercised option on common stock
Option strike price $94.10 per share Exercised option on common stock
Remaining option underlying shares 14,000 shares Option exercisable at $157.13, expires 2031-02-23
Remaining option underlying shares 4,147 shares Option exercisable at $53.94, expires 2028-03-08
Tax-withholding code Code F Disposition to pay exercise price or tax liability
Option exercise code Code M Exercise or conversion of derivative security
2020 Omnibus Equity Incentive Plan financial
"These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024."
Rule 16b-3(d) regulatory
"The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d)."
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
withholding tax obligations financial
"Shares were withheld by the Company to pay the exercise price and withholding tax obligations."
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
tax-withholding disposition financial
"transaction_action: tax-withholding disposition"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KIDD BRIAN F

(Last)(First)(Middle)
100 VINE STREET

(Street)
MURFREESBORO TENNESSEE 37130

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/14/2026M4,000(1)A$94.133,130D
Common Stock05/14/2026M500(2)A$90.6233,630D
Common Stock05/14/2026F3,134(3)D$197.9630,496(4)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock$53.9403/08/202403/08/2028Common Stock4,1474,147D
Option to Purchase Common Stock$94.105/14/2026M4,000(1)03/05/202503/05/2029Common Stock8,000$04,000D
Option to Purchase Common Stock$90.6205/14/2026M500(2)02/24/202602/24/2030Common Stock9,500$09,000D
Option to Purchase Common Stock$157.1302/23/202702/23/2031Common Stock14,00014,000D
Explanation of Responses:
1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
2. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
3. Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
4. Total amount of shares beneficially owned following transactions reported on this form.
/s/ Brian Kidd05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did NHC SVP & CFO Brian Kidd report in this Form 4 transaction?

Brian Kidd reported option exercises and related share withholdings. He exercised derivative securities for 4,500 National Healthcare Corp shares and had 3,134 shares withheld by the company to cover the option exercise price and associated tax obligations under its 2020 Omnibus Equity Incentive Plan.

Did NHC executive Brian Kidd buy or sell NHC (NHC) shares on the open market?

The filing shows compensation-related activity, not open-market trades. Kidd exercised stock options and the company withheld 3,134 shares to pay the option exercise price and tax obligations, a standard non-market mechanism rather than a discretionary stock purchase or sale transaction.

How many National Healthcare Corp shares were involved in Brian Kidd’s tax withholding?

The company withheld 3,134 shares of National Healthcare Corp common stock. These shares were used to pay the option exercise price and withholding tax obligations, according to the footnote, and are classified as a tax-withholding disposition rather than an ordinary sale into the market.

What stock options does NHC CFO Brian Kidd retain after this Form 4?

Kidd retains options linked to 14,000 and 4,147 underlying common shares. These options carry exercise prices of $157.13 and $53.94 per share, respectively, and have expiration dates in 2031 and 2028, providing potential future equity exposure if exercised later.

Under which plan were Brian Kidd’s NHC stock options granted?

The options were granted under the 2020 Omnibus Equity Incentive Plan. Footnotes state that grants on March 5, 2024 and February 24, 2025, and their exercises, are exempt from Section 16(b) short-swing profit rules pursuant to Rule 16b-3(d), reflecting standard executive compensation structuring.